Christy Chuang‐Stein

Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)

Scott Evans, Daniel B. Rubin, Dean Follmann et al. · Clinical Infectious Diseases · 2015 · 343 citations · Full text

Pharmacy, Pharmacotherapy, Antimicrobial Resistance +15

Adaptive Designs in Clinical Drug Development—An Executive Summary of the PhRMA Working Group

Paul Gallo, Christy Chuang‐Stein, Vladimir Dragalin et al. · Journal of Biopharmaceutical Statistics · 2006 · 317 citations

Medicine, Pharmacology, Clinical Pharmacology +16

Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia

Earle Bain, Laura Shafner, David P. Walling et al. · JMIR mhealth and uhealth · 2017 · 166 citations · Full text

Pharmacy, Pharmacology, Psychiatry +16

Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development

Brenda Gaydos, Keaven M. Anderson, Donald A. Berry et al. · Drug Information Journal · 2009 · 125 citations

Medicine, Pharmacology, Clinical Pharmacology +15

Sample size and the probability of a successful trial

Christy Chuang‐Stein · Pharmaceutical Statistics · 2006 · 125 citations

Public Health, Biostatistics, Clinical Pharmacology +15